← Back to Omega Healthcare Investors
Stoqly stoqly.net Company report · October 27, 2026

Omega Healthcare Investors

OHI NYSE· Health Care REITs

Last close · Oct 26, 2026

$47.01

KIRA · Stoqly’s AI analyst, in plain words

  • Omega Healthcare Investors had $1.2B of revenue in fiscal 2025, up 13.2% on the year before. Over five years, revenue changed +5.9% a year on average.
  • Omega Healthcare Investors made $590M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 0.2% a year.
  • Free cash flow was $798M in fiscal 2025, 67.0% of revenue.
  • Omega Healthcare Investors returned $780M to shareholders in fiscal 2025, 98% of free cash flow. The diluted share count rose 12.8%.
  • Omega Healthcare Investors owes $4.2B more than it holds in cash, about 3.6 years of operating profit.

Market cap

$14.9B

P/E

16.8x

Revenue

$1.2B

Net income

$590M

Free cash flow

$798M

Operating margin

—

Omega Healthcare Investors in 30 seconds · fiscal 2025

Good

Are sales growing?

+13.2%

Yes. Sales grew 13.2% last year.

Good

Does it make a profit?

49.6%

Yes. It keeps 49.6% of every sale as profit.

Good

Does profit turn into cash?

67.0%

Yes. 67.0% of sales ends up as free cash.

Weak

Is debt under control?

3.6x

Heavy. Repaying its debt would take 3.6 years of operating profit.

For information

How is the share priced?

16.8x

One share costs 16.8 times its yearly profit per share. Typical for its sector: 28.2x.

What Omega Healthcare Investors does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K · Feb 9, 2026
Legal name
OMEGA HEALTHCARE INVESTORS, INC.
CIK
0000888491
stoqly.net · OHI · Generated October 27, 2026 Not investment advice · Page 1 of 3
Stoqly stoqly.net Company report · October 27, 2026

Omega Healthcare Investors · OHI

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $1.1B $878M $950M $1.1B $1.2B
Revenue growth 19.1% −17.4% 8.1% 10.7% 13.2%
Net income $428M $439M $242M $406M $590M
Net margin 40.3% 50.0% 25.5% 38.7% 49.6%
Diluted EPS $1.75 $1.80 $1.00 $1.55 $1.94
Cash
Cash from operations $722M $626M $618M $749M $879M
Capital expenditure $44.9M $47.2M $38.0M $37.8M $80.9M
Free cash flow $677M $579M $580M $712M $798M
FCF margin 63.7% 65.9% 61.0% 67.7% 67.0%
Dividends paid $638M $633M $644M $685M $780M
Share buybacks $0.0M $142M $0.0M $0.0M $0.0M
Share count change 3.9% −0.0% 2.5% 8.0% 12.8%
Debt and strength
Cash and short-term investments $20.5M $297M $443M $518M $27.0M
Debt incl. finance leases $5.3B $5.3B $5.1B $4.8B $4.3B
Shareholders' equity $3.9B $3.6B $3.6B $4.5B $5.2B
Net debt / EBITDA 5.3x 5.0x 5.7x 4.5x 3.6x
Interest coverage 2.8x 2.9x 2.1x 2.9x 3.9x
Returns and quality
Return on capital 7.0% 7.3% 5.6% 7.3% 8.8%
Return on equity 11.1% 11.7% 6.7% 10.0% 12.2%

Insiders bought, 12 months

$1.4M

2 insiders

Insiders sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net · OHI · Generated October 27, 2026 Not investment advice · Page 2 of 3
Stoqly stoqly.net Company report · October 27, 2026

Omega Healthcare Investors · OHI

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

Similar companies

Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Omega Healthcare Investors OHI $14.9B 13.2% — 67.0% 8.8% 16.8x —
Healthcare Realty Trust HR $6.2B −6.9% — 10.8% — — —
Sabra Health Care REIT SBRA $5.0B 10.2% — — 5.1% 76.1x —
American Healthcare REIT AHR $10.4B 9.2% 18.4% — — 78.8x —
Healthpeak Properties DOC $13.4B 4.5% — 12.7% 3.2% 55.3x —

Price compared with profit (P/E)

How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.

Omega Healthcare Investors 16.8x
Similar companies 75.2x
Sector 28.2x

KIRA

At $47.01 a share, the company is worth $14.9B: 16.8 times its earnings of the last four quarters.

Omega Healthcare Investors grew sales faster than 4 of its 4 similar companies. Its P/E is higher than 0 of 3.

Source: SEC EDGAR XBRL filings (CIK 0000888491). Data updated October 18, 2026. For information only — not investment advice. Check the original filings before relying on any figure.